APA (7th ed.) Citation

Tian, T., Hong, F., Wang, Z., Hu, J., Chen, N., Lv, L., & Yi, Q. (2021). HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Tian, Tian, Fu Hong, Zhiwen Wang, Jiaru Hu, Ni Chen, Lei Lv, and Qiyi Yi. HSD17B6 Downregulation Predicts Poor Prognosis and Drives Tumor Progression via Activating Akt Signaling Pathway in Lung Adenocarcinoma. Nature Publishing Group, 2021.

MLA (8th ed.) Citation

Tian, Tian, et al. HSD17B6 Downregulation Predicts Poor Prognosis and Drives Tumor Progression via Activating Akt Signaling Pathway in Lung Adenocarcinoma. Nature Publishing Group, 2021.